Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AqueSys, Inc.
A prospective, multi-center, single arm, open-label clinical trial to evaluate the safety and IOP lowering performance of the AqueSys Microfistula Implant in refractory glaucoma patients who have previously failed a glaucoma procedure and who are not well-controlled on IOP lowering medications.
Age
45–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of Refractory Glaucoma
Maximally-tolerated medicated IOP at two preoperative visits of ≥20 mmHg and ≤35 mmHg
Visual field mean deviation score of -3 dB or worse
Shaffer Angle Grade ≥ 3
Area of free, healthy and mobile conjunctiva in the targeted quadrant
You may not be if
Active Neovascular Glaucoma
Previous glaucoma shunt/valve in the targeted quadrant
History of corneal surgery, opacities or disease/pathology
